HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Winfried S Wels Selected Research

alpha- cyano- (3,4- dihydroxy)- N- (3- phenylpropyl)cinnamide

10/2008Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Winfried S Wels Research Topics

Disease

59Neoplasms (Cancer)
10/2021 - 12/2003
7Breast Neoplasms (Breast Cancer)
10/2021 - 02/2007
5Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2016
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 01/2012
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2019 - 10/2013
4Renal Cell Carcinoma (Grawitz Tumor)
09/2012 - 05/2005
3Leukemia
01/2019 - 03/2008
3Sarcoma (Soft Tissue Sarcoma)
09/2017 - 01/2012
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2013 - 09/2009
2Melanoma (Melanoma, Malignant)
03/2021 - 11/2012
2Rhabdomyosarcoma
03/2021 - 01/2017
2Brain Neoplasms (Brain Tumor)
01/2016 - 03/2013
2Neuroblastoma
05/2015 - 10/2008
2Prostatic Neoplasms (Prostate Cancer)
03/2011 - 01/2009
1Inflammation (Inflammations)
10/2018
1Triple Negative Breast Neoplasms
01/2018
1Carcinogenesis
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2017
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
10/2016
1Residual Neoplasm
01/2016
1Infections
08/2015
1Lymphoid Leukemia
10/2013
1Neoplasm Metastasis (Metastasis)
01/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2012
1Osteosarcoma (Osteogenic Sarcoma)
10/2009
1Carcinoma (Carcinomatosis)
11/2008

Drug/Important Bio-Agent (IBA)

31Chimeric Antigen ReceptorsIBA
10/2021 - 06/2007
21AntigensIBA
10/2021 - 07/2008
14Proteins (Proteins, Gene)FDA Link
03/2021 - 03/2005
9CytokinesIBA
03/2021 - 10/2009
7Neoplasm Antigens (Tumor Antigens)IBA
10/2021 - 11/2008
7Peptides (Polypeptides)IBA
01/2021 - 03/2005
7Immunoglobulin FragmentsIBA
01/2017 - 03/2005
6LigandsIBA
10/2021 - 08/2012
6ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2007
5Immunotoxins (Immunotoxin)IBA
06/2009 - 12/2003
4Immunoglobulin G (IgG)IBA
10/2021 - 03/2005
4AntibodiesIBA
12/2020 - 01/2007
4Cetuximab (Erbitux)FDA Link
04/2016 - 01/2007
4human ERBB2 proteinIBA
04/2016 - 06/2007
4Monoclonal AntibodiesIBA
10/2013 - 01/2007
4VaccinesIBA
01/2013 - 05/2005
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2021 - 11/2012
3Surface Antigens (Surface Antigen)IBA
03/2021 - 03/2011
3Antigen Receptors (Antigen Receptor)IBA
03/2021 - 09/2012
3InterleukinsIBA
01/2017 - 09/2012
3EpitopesIBA
06/2014 - 05/2005
3Granzymes (Granzyme)IBA
08/2013 - 08/2012
3Epithelial Cell Adhesion MoleculeIBA
09/2012 - 01/2009
2epidermal growth factor receptor VIIIIBA
01/2019 - 04/2016
2AutoantigensIBA
01/2017 - 09/2012
2Rituximab (Mabthera)FDA Link
10/2013 - 03/2008
2IronIBA
03/2013 - 03/2011
2Interleukin-15 (Interleukin 15)IBA
09/2012 - 09/2012
2Indicators and Reagents (Reagents)IBA
08/2012 - 12/2003
2B7 AntigensIBA
11/2008 - 05/2005
1SuspensionsIBA
03/2021
1fms-Like Tyrosine Kinase 3IBA
10/2019
1CD19-specific chimeric antigen receptorIBA
01/2019
1Frizzled ReceptorsIBA
01/2019
1Cell Surface ReceptorsIBA
01/2019
1CateninsIBA
01/2018
1Natural Killer Cell ReceptorsIBA
09/2017
1Differentiation AntigensIBA
01/2017
1interleukin-21 (interleukin 21)IBA
01/2017
1Pharmaceutical PreparationsIBA
05/2015
1Doxycycline (Periostat)FDA LinkGeneric
06/2014
1Fc Receptors (Fc Receptor)IBA
10/2013
1ofatumumabFDA Link
10/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013
15-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA
01/2013
1PerforinIBA
01/2013
1Monophenol Monooxygenase (Tyrosinase)IBA
11/2012
1Cancer VaccinesIBA
09/2012
1Apoptosis Regulatory ProteinsIBA
08/2012
1ferric oxide (iron oxide)IBA
03/2011
1ferumoxides (Feridex)FDA Link
03/2011
1OxidesIBA
03/2011
1Apoptosis Inducing FactorIBA
06/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2009
1Coloring Agents (Dyes)IBA
01/2009
1DNA (Deoxyribonucleic Acid)IBA
11/2008
1DNA VaccinesIBA
11/2008
1ExotoxinsIBA
10/2008
1alpha- cyano- (3,4- dihydroxy)- N- (3- phenylpropyl)cinnamideIBA
10/2008
1Tyrosine Kinase InhibitorsIBA
10/2008
1Transforming Growth Factor alpha (TGF-alpha)IBA
10/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2008

Therapy/Procedure

28Therapeutics
03/2021 - 12/2003
25Immunotherapy
03/2021 - 01/2007
2Cell- and Tissue-Based Therapy (Cell Therapy)
03/2021 - 03/2013
2Aftercare (After-Treatment)
01/2017 - 01/2016
2Stem Cell Transplantation
06/2014 - 01/2012
2Intravenous Injections
01/2013 - 03/2011
1Investigational Therapies (Experimental Therapy)
03/2021
1Microbubbles
01/2016
1Adjuvant Chemoradiotherapy
01/2016
1Hematopoietic Stem Cell Transplantation
08/2015
1Haploidentical Transplantation
06/2014